EWM
NVO

Endurance Wealth Management’s Novo Nordisk NVO Stock Holding History

Endurance Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-20
Closed -$1K – 636
2021
Q1 		$1K Hold
20
– – ﹤0.01% 628
2020
Q4 		$1K Hold
20
– – ﹤0.01% 600
2020
Q3 		$1K Hold
20
– – ﹤0.01% 602
2020
Q2 		$1K Hold
20
– – ﹤0.01% 593
2020
Q1 		$1K Buy
+20
New +$596 ﹤0.01% 556

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Endurance Wealth Management's NVO Position: Q2 2021 in Review

Endurance Wealth Management sold out of Novo Nordisk (NVO) in Q2 2021, closing a stake of 20 shares — an estimated $1K sold.

Endurance Wealth Management first reported a position in NVO in Q1 2020 and held it in 5 quarters. The position peaked at $1K in Q1 2021. 735 funds tracked by Wall St. Rank hold NVO as of Q2 2021.

  • Endurance Wealth Management reported no remaining Novo Nordisk position as of Q2 2021 after selling out during the quarter.
  • Endurance Wealth Management sold 20 Novo Nordisk shares in Q2 2021, an estimated $1K.
  • Endurance Wealth Management first reported a position in Novo Nordisk in Q1 2020 and held it in 5 quarters.
  • Endurance Wealth Management's Novo Nordisk position peaked at $1K in Q1 2021.
  • 735 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2021.

Based on Endurance Wealth Management's 13F filing for Q2 2021, filed 4 Aug 2021.